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Oxidative damage to unsaturated lipids (lipid peroxidation) is a well-established general mechanism for cellular injury (1) (2) (3) . In addition to extensive experimental studies increased lipid peroxidation has been reported in a wide variety of clinical and toxicological conditions, including acute myocardial infarction, stroke, diabetes mellitus, rheumatic disorders, hepatic diseases, burns, and toxicity by certain drugs, pesticides, and metals (4-12).
Lipoperoxides in serum or plasma are most frequently measured as the malondialdehyde-thiobarbituric acid adduct (MDA-TBA), a red complex with maximum absorption at 532 rim (13) . It has been quantified by spectrophotometry (5, 14), fluorometry (15) , and liquid chromatography (16). However, measurement by either spectrophotometry or fluorometry includes various interfering compounds, thereby decreasing the specificity of the method (17, 18). Wong et al. (19) recently reported an improved liquidchromatographic procedure for measuring MDA in plasma, and reliable reference values for this method have now been published (20) . MDA has also been measured in urine of rats by liquid chromatography (21, 22) . In these studies, the urinary excretion of MBA was noted to be increased by dietary fatty acids, and by the administration of corticotropin, epinephrine, adriamycin, and carbon tetrachlonde.
In the current study, we describe an adaptation to urine of the improved liquid-chromatographic method for plasma (19) . In addition, we determined reliable reference values on untimed urine specimens from men and women. Our early observations suggest that under some conditions, assay of MBA in urine may be preferred to assays in plasma.
Materials and Methods
Subjects: Untimed specimens of urine were obtained from men and women laboratory employees, other hospital employees who were undergoing annual physical examinations, and from other individuals undergoing pre-employment evaluations.
The urine specimens from this latter group were all negative when screened for various drugs. All individuals were working and considered to be in good health (Table 1 ). In addition, plasma from EDTA-anticoagulated venous blood and untimed urine specimens were obtained from five renal-transplant patients, all of whom were on cyclosporine ( Table 2 ). All specimens were stored at 4#{176}C until analyzed, usually within 24 h.
Apparatus: The liquid-chromatographic (LC) equipment has been recently described (19, 20) . However, we used larger urine volumes, so the recorder sensitivity was decreased to 0.05 A full scale. In the current study, the life of the C18 column was prolonged and the quality of the chromatogranis was improved by the following changes in technique:
(a) Each day before the initial sample injection, 100 L of undiluted 99.9% dimethyl sulfoxide (DMSO) was injected into the LC apparatus.4 The system was then purged with mobile phase to cleanse it of any residual DMSO.
(b) Column life was further prolonged by decreasing the methanol concentration of the mobile phase from 400 mL/L to 350 mLIL. Although this prolonged the retention time of the MDA-TBA peak and resulted in slightly smaller and broader peaks, we saw no measurable differences in accuracy or precision. We used this concentration change only when the column had been used for some time and the MDA-TBA peak began to merge with the large earlier solvent/reagent front.
These two procedures prolonged the column life by apRecommendation from Dr. StevenH. Y. Wong, Farnungton, CT.
proximately 25% over our previous experience (19,20). (c) We initially used polypropylene tubes for the lipoperoxide hydrolysis step, resulting in a small contamination peak readily seen in the blank sample (19). Efforts to remove this contamination were not completely successful. When glass tubes were substituted, there was no contamination ( Figure IA) .
Reagents: All reagents, chemicals, and solvents were exactly as previously described (19). However, the tetraethoxypropane (TEP) standard solutions were prepared as follows. The stock TEP solution (2.02 mmol/L) was prepared by diluting 25 pL of 1,1,3,3-tetraethoxypropane (Sigma Chemical Co., St. Louis, MO; cat no. T-9889, 97-98% anhydrous, relative density 0.91, relative molecular mass 220.3) to the mark in a 50-mL volumetric flask with ethanol/water solution (40/60 by vol) and stored at 4#{176}C. It was prepared bi-weekly.
TEP working standard solutions (0.60, 2.40, and 4.00 tmo1JL) were prepared by placing 15, 60, and 100 p.L of the TEP stock standard in three 50-mL volumetric flasks and diluting to the mark with the ethanol/water solution. These working standards, prepared bi-weekly, contained 0.36, 1.45, and 2.42 nmol/0.6 mL, and were stored at 4#{176}C.
Lipoperoxide hydrolysis and TBA reaction. In each analytical run, reagent blank, quality-control specimen, TEP working standard solutions, and urine samples are assayed. Because the MDA-TBA adduct is unstable at neutral or alkaline pH, the boiled samples are neutralized individually within 10 mm of injection onto the LC column. Pipet 0.5 mL of each boiled sample into a polypropylene microtube that contains 0.5 mL of methanol-NaOH solution. The tubes are then capped, vortex-mixed, and centrifuged at 9500 x g for 90 s to sediment the precipitated proteins.
Liquid-chromatographic analysis. The MBA concentration is determined by injecting 50 L of each neutralized, centrifuged sample into the LC apparatus and measuring the peak height at 532 urn as previously described (19). At a flow rate of 2.0 mL/min, the MDA-TBA adduct elutes at about 4.2 mm (Figure 1) . Urine creatinine (Cr). Urine creatinine (Cr) concentrations (mg/dL) were determined in an Astra chemistry analyzer as described by the manufacturer (Beckman Instruments Inc., Fullerton, CA 92634).
Urine MDA concentration. The MBA concentration in urine is calculated by use of the following equation:
Urine MBA (nmol/mg Cr) = nrnolJO.6 mL urine x 1.67 X 100/mg Cr where the value for nmol MDA/O.6 mL urine is taken directly from the standard curve and 1.67 is the conversion factor to correct the urine volume to 1.0 mL. Spectral analysis. We performed a spectral study, using a urine specimen that showed multiple peaks (see Figure 1) . We measured the peak heights at 512, 522, 532, 542, and 552 urn. The absorbance maximum, as expected, was at 532 urn; the absorbance at 522 urn was 95% of the 532 nm peak. The peak heights at both 512 and 542 urn were about 55% of the 532 urn peak. There was no absorbance at 552 nm.
Sensitivity, precision, and recovely. The detection limit of this method, determined by progressively diluting a pooled urine specimen with isotonic saline, is about 0.08 pmol/L. This concentration is well below that seen in all but the most dilute urine samples. We evaluated within-nm and nm-to-run precision by using two pooled urine specimens ( Table 3 ). The pooled specimens for the run-to-run study were aliquoted and refrigerated at 4#{176}C. The MBA concentration in urine was stable for at least two weeks. Analytical recovery from urine averaged 96% (range 90-103%) when a TEP standard containing 1.66 unol of MBA per liter was added to a urine specimen pool having a MBA concentration of 0.64 (0.04) p.molJL (n = 10).
Tests for interference. Addition of the following substances to normal urine, at the concentrations indicated, did not interfere in the assay: glucose (555 mrnoIJL), protein (2 g/L), acetoacetic acid (1.66 mmol/L), acetylsalicylic acid (1.66 mmol/L), acetaminophen (2.0 mmol/L), phenobarbital (0.20 mmol/L), and amphetamine (6.0 mmoIJL). Bilirubin has previously been shown not to interfere with the TBA reaction (19, 23) , although biliverdin, present in icteric serum and bile, causes positive interference (23) .
Statistical analyses. Data computations included the means, standard deviations, and Student's t-test. Outliers were removed according to Barnett (24) , three outliers from both of the reference groups.
Results and Discussion
Increased lipid peroxidation, demonstrated most frequently in humans by increased MBA concentrations in serum or plasma, has recently been reported in a wide variety of clinical and toxicological conditions (4-12) . Although urinary MBA concentrations have been measured in laboratory animals (21,22), to our knowledge they have not been previously reported in humans.
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In this paper we report our early studies on the measure- 21,22) . In this regard, Figure 1 demonstrates that, in contrast to plasma, multiple chromophores are present in urine. However, these are readily separated from each other, and the MDA-TBA peak is only rarely affected. Figure 1C shows the most common pattern noted, although there was considerable variation in the concentration of the chromophore immediately following the MDA-TBA peak. In addition, Figure ID demonstrates the complexity of chromatograms often seen in some urmnes and points to the analytical problems of measuring MDA in biological specimens by spectrophotometry or fluorometry (17, 18). However, the addition to urine of glucose, protein, bilirubin, acetoacetic acid, phenobarital, amphetamine, acetylsalicylic acid, and acetaminophen does not interfere with the assay. Table 3 shows the within-nm and run-to-run precision, which is similar to that reported for plasma (19, 20) . The detection limit is about 0.08 zmoI/L, a value considerably lower than seen for all but the most dilute urine specimens.
We measured MBA in untimed urine specimens from 107 women, ages 15 to 55 years, and 121 men, ages 16 to 67 years ( Table 1) . It is apparent that reference values for men significantly exceed those for women (P = 0.015), a finding in agreement with recently reported values for plasma (20) . We also studied five renal-transplant patients, all of whom were on cyclosporine medication and doing well clinically (Table 2) . In all cases, the concentrations in plasma were within the reference interval (20) . However, two urine samples showed moderate MBA elevations, two others were at the upper limit of the reference interval, and the fifth exceeded the reference mean. This mini-study suggests that urinary MBA measurements may be a more sensitive and specific indicator of lipid peroxidation than concentrations in plasma, at least in disorders of renal function. Whether these increased values for MBA represent mild cyclosporine toxicity, normal immunological effects, or other as-yetundefined effects is not known. An extension of the studies reported here is needed to better understand these findings.
